These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 31387385

  • 1. Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.
    Fritzen K, Basinska K, Stautner C, Braun KF, Rubio-Almanza M, Nicolucci A, Kennon B, Vergès B, Hosny Y, Schnell O.
    J Diabetes Sci Technol; 2020 Mar; 14(2):262-270. PubMed ID: 31387385
    [Abstract] [Full Text] [Related]

  • 2. Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management.
    Fritzen K, Basinska K, Rubio-Almanza M, Nicolucci A, Kennon B, Vergès B, Zakrzewska K, Schnell O.
    J Diabetes Sci Technol; 2019 Nov; 13(6):1112-1122. PubMed ID: 30917691
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System.
    Fritzen K, Gutschek B, Coucke B, Zakrzewska K, Hummel M, Schnell O.
    J Diabetes Sci Technol; 2018 Sep; 12(5):1002-1006. PubMed ID: 29436251
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    Bidonde J, Fagerlund BC, Frønsdal KB, Lund UH, Robberstad B.
    ; 2017 08 21. PubMed ID: 29553668
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL, Willis WD, Foos V.
    Curr Med Res Opin; 2010 Jan 21; 26(1):163-75. PubMed ID: 19919377
    [Abstract] [Full Text] [Related]

  • 10. Patient Satisfaction With a New, High Accuracy Blood Glucose Meter That Provides Personalized Guidance, Insight, and Encouragement.
    Katz LB, Stewart L, Guthrie B, Cameron H.
    J Diabetes Sci Technol; 2020 Mar 21; 14(2):318-323. PubMed ID: 31375031
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of OneTouch Verio(®), a new blood glucose self-monitoring system for patients with diabetes.
    Littmann K, Petersen ER, Pussinen C, Danielson K, Djurisic S, Eilertsen H, Garabet L, Greibe E, Lauritzen T, Olsen DA, Othman S, Palimaru I, Westerlund J.
    Scand J Clin Lab Invest; 2013 Mar 21; 73(4):286-92. PubMed ID: 23473019
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
    Roze S, Isitt J, Smith-Palmer J, Javanbakht M, Lynch P.
    Diabetes Care; 2020 Oct 21; 43(10):2411-2417. PubMed ID: 32647050
    [Abstract] [Full Text] [Related]

  • 14. Cost of poor adherence to anti-hypertensive therapy in five European countries.
    Mennini FS, Marcellusi A, von der Schulenburg JM, Gray A, Levy P, Sciattella P, Soro M, Staffiero G, Zeidler J, Maggioni A, Schmieder RE.
    Eur J Health Econ; 2015 Jan 21; 16(1):65-72. PubMed ID: 24390212
    [Abstract] [Full Text] [Related]

  • 15. Interactive Exposure With a Blood Glucose Monitor With a Novel Glucose Color Range Indicator Is Associated With Improved Glucose Range Interpretation and Awareness in Patients With Type 2 Diabetes.
    Grady M, Warren G, Levy BL, Katz LB.
    J Diabetes Sci Technol; 2015 Jul 21; 9(4):841-8. PubMed ID: 25652564
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries.
    Yoo HK, Byun HG, Caprioli F, Fumery M, Peyrin-Biroulet L, Sreedhar S, Potter J, Jang M.
    BMC Health Serv Res; 2022 Nov 04; 22(1):1319. PubMed ID: 36333704
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.